A Randomised Controlled Phase II Trial of Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast Cancer.
A randomised controlled trial of vinorelbine plus capecitabine versus docetaxel plus
capecitabine in anthracycline-pretreated women with metastatic breast cancer. The primary
endpoints of the study is progression free survival (PFS). The secondary endpoints are
overall response rate (ORR), overall survival (OS) and safety.
Observational Model: Case Control, Time Perspective: Prospective
China: Food and Drug Administration